» Articles » PMID: 39086621

Diabetes Management in the Era of Artificial Intelligence

Overview
Date 2024 Aug 1
PMID 39086621
Authors
Affiliations
Soon will be listed here.
Abstract

Artificial intelligence is growing quickly, and its application in the global diabetes pandemic has the potential to completely change the way this chronic illness is identified and treated. Machine learning methods have been used to construct algorithms supporting predictive models for the risk of getting diabetes or its complications. Social media and Internet forums also increase patient participation in diabetes care. Diabetes resource usage optimisation has benefited from technological improvements. As a lifestyle therapy intervention, digital therapies have made a name for themselves in the treatment of diabetes. Artificial intelligence will cause a paradigm shift in diabetes care, moving away from current methods and toward the creation of focused, data-driven precision treatment.

References
1.
Patel M, Asch D, Volpp K . Wearable devices as facilitators, not drivers, of health behavior change. JAMA. 2015; 313(5):459-60. DOI: 10.1001/jama.2014.14781. View

2.
Zueger T, Schallmoser S, Kraus M, Saar-Tsechansky M, Feuerriegel S, Stettler C . Machine Learning for Predicting the Risk of Transition from Prediabetes to Diabetes. Diabetes Technol Ther. 2022; 24(11):842-847. DOI: 10.1089/dia.2022.0210. View

3.
Zee B, Lee J, Lai M, Chee P, Rafferty J, Thomas R . Digital solution for detection of undiagnosed diabetes using machine learning-based retinal image analysis. BMJ Open Diabetes Res Care. 2022; 10(6). PMC: 9809219. DOI: 10.1136/bmjdrc-2022-002914. View

4.
Bellemo V, Lim Z, Lim G, Nguyen Q, Xie Y, Yip M . Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study. Lancet Digit Health. 2020; 1(1):e35-e44. DOI: 10.1016/S2589-7500(19)30004-4. View

5.
Baig M, GholamHosseini H, Gutierrez J, Ullah E, Linden M . Early Detection of Prediabetes and T2DM Using Wearable Sensors and Internet-of-Things-Based Monitoring Applications. Appl Clin Inform. 2021; 12(1):1-9. PMC: 7787711. DOI: 10.1055/s-0040-1719043. View